What are the diagnostic approach and recommended treatments for parasitic lung infections such as strongyloidiasis, ascariasis, paragonimiasis, toxocariasis, and filarial infections?

Parasitic Lung Infections: Diagnostic Approach and Treatment

For parasitic lung infections, prioritize serology as the primary diagnostic tool combined with concentrated stool microscopy or PCR, and treat empirically with ivermectin 200 μg/kg plus albendazole 400 mg as a single dose when no organism is identified, while avoiding corticosteroids until strongyloidiasis is definitively excluded to prevent fatal hyperinfection syndrome. 1

Diagnostic Approach

Initial Investigation Strategy

The diagnostic workup should be guided by:

• Travel/residence history to endemic regions (Africa, Asia, South America, West Africa for specific parasites)
• Timing of symptoms relative to exposure (incubation periods vary: 1-2 weeks for Loeffler's syndrome, up to 1 year for tropical pulmonary eosinophilia)
• Presence and degree of eosinophilia (though notably, hyperinfection strongyloidiasis may present with normal eosinophil counts) 1

Specific Diagnostic Tests by Pathogen

Strongyloidiasis:

• Serology at specialist laboratories (first-line)
• Concentrated stool microscopy (very low sensitivity)
• Faecal PCR and Strongyloides stool culture at specialist laboratories (more sensitive)
• Critical: In suspected hyperinfection, urgent stool AND sputum microscopy for larvae is essential; larvae in sputum or bronchoalveolar lavage highly suggests hyperinfection 1

Ascariasis:

• Concentrated stool microscopy or faecal PCR
• May present with Loeffler's syndrome (fever, urticaria, wheeze, dry cough) 1-2 weeks post-exposure
• Larvae rarely seen in sputum or bronchoalveolar lavage 1

Paragonimiasis:

• Serology (specialist laboratories)
• Concentrated stool microscopy or faecal PCR
• Presents with pleuritic chest pain, pleural effusion, hemoptysis
• Endemic in East Asia, Southeast Asia, West Africa, Pacific coast of Latin America, and North America 1, 2

Toxocariasis (Visceral Larva Migrans):

• Serology for infection diagnosis
• Clinical presentation: fever, eosinophilia, dyspnoea, wheeze, cough in children <5 years or adults consuming raw meat
• Ocular toxocariasis occurs without eosinophilia and requires formal ophthalmological examination 1

Tropical Pulmonary Eosinophilia (Filarial):

• Pan-filarial antibody ELISA (sensitivity 90-99%)
• Presents with fever, dry cough, wheeze, dyspnoea; often misdiagnosed as asthma
• Incubation up to one year
• Updated guidance: Filarial investigations now only recommended for those with West Africa travel/residence history 1

Treatment Recommendations

Empirical Treatment for Unidentified Loeffler's Syndrome

When no organism is identified after initial workup:

• Ivermectin 200 μg/kg single dose PLUS albendazole 400 mg single dose 1
• Consider retreatment 1 month after resolution of pulmonary symptoms to ensure adult worms are treated 1

Pathogen-Specific Treatment

Strongyloidiasis:

• Standard treatment: Ivermectin 200 μg/kg daily for 2 days
• Hyperinfection/disseminated disease: Ivermectin 200 μg/kg daily, continue until larvae negative for 2 weeks (may require parenteral formulation)
• Critical warning: This is a medical emergency with high mortality if untreated; early initiation of ivermectin is curative 2, 3, 4

Ascariasis:

• Albendazole 400 mg single dose OR
• Mebendazole 500 mg single dose OR
• Ivermectin 200 μg/kg single dose 1

Paragonimiasis:

• Praziquantel 25 mg/kg three times daily for 2-3 days
• Alternative: Triclabendazole (requires specialist procurement) 1

Toxocariasis:

• Visceral larva migrans: Albendazole 400 mg twice daily for 5 days
• Ocular disease: Requires joint ophthalmology care; albendazole 400 mg twice daily for 3-14 days depending on severity
• Severe disease: Add prednisolone 40-60 mg once daily 1

Tropical Pulmonary Eosinophilia:

• Diethylcarbamazine (DEC) is standard treatment (requires specialist procurement)
• Treatment duration typically 2-3 weeks 1

Critical Clinical Pitfalls

Corticosteroid Use - The Fatal Error

Never administer corticosteroids before excluding strongyloidiasis. Corticosteroids can trigger hyperinfection syndrome, presenting with:

• Bacteremia and meningitis from enteric organisms
• Pulmonary hemorrhage
• Gastrointestinal bleeding or obstruction
• Mortality rates are significant if not recognized early 1, 2, 3

High-Risk Populations Requiring Screening

Screen for strongyloidiasis before immunosuppression in:

• Patients from endemic regions (warm/tropical areas worldwide)
• Those requiring corticosteroid therapy
• Organ transplant candidates
• Patients starting immunosuppressive medications
• Chronic infection can persist for decades after leaving endemic regions 2, 3, 4

Diagnostic Challenges

• Serology may remain positive for years after successful schistosomiasis treatment, so cannot assess treatment success 1
• Microfilaremia is detectable in only one-third of Loa loa infections, requiring alternative diagnostic approaches 5
• Eosinophilia may be absent in hyperinfection strongyloidiasis, making diagnosis more challenging 1

Special Considerations

Pregnancy and Lactation

Most antiparasitic medications have limited data in pregnancy. Albendazole and ivermectin have very low levels in breastmilk and are likely compatible with breastfeeding. Praziquantel lacks maternal systemic absorption, making transfer to breastmilk unlikely 1

Drug Procurement

Many antiparasitic medications are not routinely stocked in non-endemic countries. Contact specialist tropical medicine centers or national reference laboratories for drug procurement and treatment guidance 1